Pioneering Mental Health Treatment

The Future of Mental Health Care Is Here

Following President Trump’s historic executive order, Claritiv Health is committed to bringing FDA-approved psychedelic therapies to veterans and civilians suffering from PTSD, depression, and treatment-resistant conditions.
April 18, 2026

A Turning Point in Mental Health Treatment

President Trump signed an executive order to accelerate access to psychedelic therapies for patients with serious mental illness, particularly our nation’s veterans.

What the Executive Order Does

This landmark order directs the FDA and DEA to establish pathways for patients to access investigational psychedelic drugs, including ibogaine, psilocybin, and MDMA, that are currently under FDA review and have met basic safety requirements.

Fast-Track FDA Approvals

National Priority Vouchers for psychedelic drugs with Breakthrough Therapy designation, cutting red tape and accelerating review timelines.

Right to Try Access

Eligible patients can access investigational psychedelics (especially ibogaine) still under FDA review through expanded Right to Try pathways.

$50 Million in Federal Funding

ARPA-H matching grants for states investing in psychedelic research programs for serious mental illness populations.

DEA Rescheduling Initiative

Attorney General will review successful Phase 3 clinical trials for immediate rescheduling upon FDA approval, making treatments prescribable.

14M+

American adults with serious mental illness

6,000+

Veteran suicides annually for 20+ years

2x

Veteran suicide rate vs. civilian population

Our Promise

Claritiv's Commitment to Pioneering Care

We are monitoring FDA approval pathways and preparing to offer these breakthrough treatments the moment they become legally available.

Ibogaine Therapy

Psilocybin Therapy

MDMA-Assisted Therapy

We are actively preparing our clinical team, facilities, and protocols to deliver these treatments safely and effectively once approved.

Honoring Those Who Served

Special Veterans Program

At Claritiv, we recognize the unique mental health challenges faced by our nation’s veterans. We’re committed to making treatment accessible and affordable.

Veterans Discount Program

20% OFF

All honorably discharged veterans receive 20% off ketamine infusion therapy and all future FDA-approved psychedelic treatments. Valid military ID required.

Why Veterans Choose Claritiv

Specialized PTSD Treatment

Our ketamine protocols are specifically designed for combat-related trauma and service-related PTSD.

Understanding Team

We work closely with VA mental health providers and understand the unique challenges veterans face.

Early Access Commitment

Veterans will be prioritized for new psychedelic treatments as they receive FDA approval.

No Waiting Required

Ketamine Therapy Available Today

While we prepare for future psychedelic therapies, ketamine infusion is FDA-approved, proven effective, and available now for immediate relief.

Conditions We Treat with Ketamine

Treatment-Resistant Depression

PTSD

Anxiety Disorders

Major Depressive Disorder

Suicidal Ideation

Chronic Pain

Ketamine infusion therapy has been shown to provide rapid relief, often within hours, for patients who haven’t responded to traditional antidepressants. It’s a bridge to healing while we await the next generation of psychedelic therapies.

Support & Information

Veterans Resources

You’re not alone. Access critical mental health support and learn more about the government’s psychedelic therapy initiative.

🆘 Veterans Crisis Line

24/7 confidential support for veterans in crisis. Call 988, then press 1.

🏥 VA Mental Health Services

Access VA mental health care, PTSD treatment, and counseling services.

📄 White House Fact Sheet

Official details on the psychedelic therapy executive order.

🔬 FDA Right to Try

Learn about accessing investigational treatments under the Right to Try Act.

Stay Informed on New Treatments

Get email updates when FDA-approved psychedelic therapies become available at Claritiv.